135 filings
Page 5 of 7
8-K
zmtaukxass0vv0
5 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
mg2hx n0g5tc
8 Nov 17
Ophthotech Reports Third Quarter 2017 Financial and Operating Results
12:00am
8-K
0g5c4
7 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
3xjhv43pwdh
27 Oct 17
Termination of a Material Definitive Agreement
12:00am
8-K
hgi2shl9 35nxzc8i
14 Aug 17
Ophthotech Announces Results from Third Phase 3 Trial of Fovista® in Wet Age-Related Macular Degeneration
12:00am
8-K
h6cm4
26 Jul 17
Results of Operations and Financial Condition
12:00am
8-K/A
84o72zacle9 d6cbj43h
26 Jul 17
Regulation FD Disclosure
12:00am
8-K
utn ioz8r2y
10 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
syphx537 o54
22 May 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
h0wg6y62
3 May 17
Ophthotech Reports First Quarter 2017 Financial and Operating Results
12:00am
8-K
i5t508zu3 p2o6d
24 Apr 17
Departure of Directors or Certain Officers
12:00am
8-K/A
hue7sv
31 Mar 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ggxrywjl5uqqvqar4
28 Feb 17
Ophthotech Reports Fourth Quarter and Full Year 2016 Financial and Operating Results
12:00am
8-K
l52get ti1m
24 Feb 17
Departure of Directors or Certain Officers
12:00am
8-K
3hi plsvveq
1 Feb 17
Termination of a Material Definitive Agreement
12:00am
8-K
fqumu7rbggclvd9ww6jx
17 Jan 17
Departure of Directors or Certain Officers
12:00am
8-K/A
by8mewl
17 Jan 17
Cost Associated with Exit or Disposal Activities
12:00am
8-K
3yso sv4d8xrcqo
6 Jan 17
Termination of a Material Definitive Agreement
12:00am
8-K
z0vetplcxzzwalqr
16 Dec 16
Cost Associated with Exit or Disposal Activities
12:00am
8-K
mksqw3c1
12 Dec 16
Other Events
12:00am